Testing blood vessel function after a heart transplant
Part of Heart & circulation clinical trials.
This trial measures how well tiny blood vessels in the heart are working in people who have had a heart transplant. It may help doctors understand transplant-related circulation problems and guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be an adult (18 years or older).
- Have had a heart transplant.
- Agree to take part and sign informed consent.
- Not be in cardiogenic shock (a life-threatening heart pumping emergency).
- Be stable enough to safely have a coronary angiography (a heart blood-vessel imaging test).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a newer CT scan (called PCCT) with standard tests to check for a condition called cardiac allograft vasculopathy, which can narrow the arteries in a transplanted heart. The goal is to see if the newer scan works as well as the traditional method, while being less invasive.
This study investigates a new heart scan (called a cardiac PET) to detect early signs of blood vessel disease in heart transplant patients. If you had your transplant 2 to 10 years ago, this scan might be an alternative to the usual yearly checkup with an invasive procedure (angiogram).
This study tests antiplatelet medicines (like aspirin or clopidogrel) in people who have had a heart transplant. The goal is to see if these medicines can safely help prevent blood-related complications after transplant.
This study measures how well the heart’s tiny blood vessels work in people with cardiac amyloidosis, using special heart testing. It may help doctors understand the disease better and improve how patients are evaluated over time.
This study looks at how tiny blood vessels in the body work over time in people who have had a heart transplant. It aims to better understand changes in blood flow and how these may relate to health after transplant.
This trial studies whether a newer “tissue-engineered” blood vessel graft is safe and works well in children who need a specific heart surgery connection outside the heart. It may help by offering a new type of graft, but your team will screen for size and medical factors first.
Hear when a new Cardiac Allograft Vasculopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.